跳轉至內容
Merck
  • Oral bullous eruption after taking lisinopril--case report and literature review.

Oral bullous eruption after taking lisinopril--case report and literature review.

Wiener klinische Wochenschrift (2013-06-25)
Marinka Baričević, Marinka Mravak Stipetić, Mirna Situm, Branka Marinović, Sven Seiwerth, Denis Baričević, Božana Lončar
摘要

Drug-induced lesions of oral mucosa are well-established side effect of different commonly used drugs. A female patient under treatment for hypertension with an angiotensin-converting enzyme inhibitor (ACE inhibitor), lisinopril, developed blisters and ulcerations on oral mucosa 3 weeks after lisinopril intake. Due to clinical finding drug-induced pemphigus was considered. However, direct and indirect immunofluorescence anal-ysis revealed no autoantibodies that are commonly present in pemphigus while histological study suggested allergic reaction. Lisinopril was discontinued from further therapy and after a month after her first arrival patient has experienced complete remission of the disease. This case raises the question, whether the term pemphigus in drug-induced reactions could be used when immunopathological criteria for pemphigus are not fulfilled.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
赖诺普利, ≥98% (HPLC)
Supelco
赖诺普利, Pharmaceutical Secondary Standard; Certified Reference Material
USP
赖诺普利, United States Pharmacopeia (USP) Reference Standard
赖诺普利 二水合物, European Pharmacopoeia (EP) Reference Standard